Thomas Earley, D.D.S.; Decision and Order
By Justice Department, Drug Enforcement Administration
Originally at federalregister.gov
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
The DEA has revoked the controlled-substance registration of Thomas Earley, D.D.S., effectively barring him from prescribing or handling Schedule II-V drugs; any practice that still lists him as a DEA registrant risks immediate compliance violations and potential sanctions.
Key points
- Revocation took effect after a formal DEA hearing and Final Order published in the Federal Register; the dentist’s DEA number is now invalid nationwide.
- Dental practices, DSOs, and Medicaid/HHS-OIG billing systems must remove Dr. Earley from all controlled-substance prescribing roles and update internal controlled-drug logs within 24–48 hours.
- Staff and owners should run an immediate NPI/DEA cross-check on all providers; failure to do so exposes the practice to DEA audits, claim denials, and possible civil monetary penalties.
- This enforcement action underscores heightened federal scrutiny of dentists who mishandle opioids or benzodiazepines—practices should verify that all prescribers maintain active, unencumbered DEA registrations.
Who should care
Read the original on Federal Register (dental)
Full reporting and any paywall content live on federalregister.gov. We summarize and score; we do not republish.
Related
- ·Business
Why the dental assistant shortage could get worse
- ·Business
US Oral Surgery Management exec on M&A: ‘We’ve had to be even more disciplined’
- ·Research
Vertical dimension of occlusion restoration using a digital injectable composite resin technique: A 5-year clinical follow-up
- ·Research
A digitally guided workflow integrating tooth preparation and restoration positioning for minimally invasive veneer and partial-coverage restorations: A dental technique